The CMG helicase and cancer: a tumor “engine” and weakness with missing mutations

Shengyan Xiang, Damon R. Reed, Mark G. Alexandrow

Open source

DOI
10.1038/s41388-022-02572-8
Published
2022-12-15
Container
Oncogene
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41388-022-02572-8,
  title = {The CMG helicase and cancer: a tumor “engine” and weakness with missing mutations},
  author = {Shengyan Xiang and Damon R. Reed and Mark G. Alexandrow},
  year = {2022},
  journal = {Oncogene},
  doi = {10.1038/s41388-022-02572-8},
  url = {https://doi.org/10.1038/s41388-022-02572-8}
}

RIS

TY  - JOUR
TI  - The CMG helicase and cancer: a tumor “engine” and weakness with missing mutations
AU  - Shengyan Xiang
AU  - Damon R. Reed
AU  - Mark G. Alexandrow
PY  - 2022
JO  - Oncogene
DO  - 10.1038/s41388-022-02572-8
UR  - https://doi.org/10.1038/s41388-022-02572-8
ER  - 

APA

Xiang, S., Reed, D. R., & Alexandrow, M. G. (2022). The CMG helicase and cancer: a tumor “engine” and weakness with missing mutations. Oncogene. https://doi.org/10.1038/s41388-022-02572-8

Source records